Skip to content

A Study on the Efficacy and Safety of Five-Fingered Maotiao Fuling Moisture-Eliminating Paste for Removing Dampness and Reducing Fat

A Study on the Efficacy and Safety of Five-Fingered Maotiao Fuling Moisture-Eliminating Paste for Removing Dampness and Reducing Fat

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000779
Enrollment
Unknown
Registered
2026-03-27
Start date
2025-12-19
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eliminate dampness and reduce fat

Interventions

Test group:Five-Fingered Maotiao Fuling Moisture-Relieving Paste Take twice daily, 2 scoops (20g) per dose, for 56 consecutive days.

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–65 years, male or female; 2. BMI = 24.0 kg/m²; 3. Meets criteria for phlegm-dampness constitution: Based on the Chinese Association of Traditional Chinese Medicine's "Classification and Assessment of Traditional Chinese Medicine Constitutions" standards, the "TCM Constitution Questionnaire" was developed. A phlegm-dampness constitution conversion score = 40 indicates 'Yes'; a score of 30–39 indicates "Tendency towards Yes"; a score 40, other constitutional imbalances =40 but lower than phlegm-damp score); 4. Weak spleen-stomach function (frequent occurrence of poor appetite, abdominal distension, loose and sticky stools within the past 3 months); 5. Able to complete the clinical study according to protocol requirements; agrees to and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with secondary obesity: those with hypothalamic syndrome, pituitary tumors, Cushing's syndrome, hypothyroidism, hypogonadism, hyperadrenocorticism, etc.; 2.Individuals currently undergoing or who have undergone other weight-loss treatments within the past 3 months; 3.Those with allergies to any product ingredients; 4.Patients with severe concomitant cardiovascular, pulmonary, hepatic, renal, or endocrine disorders requiring disease management protocols; 5.Women planning pregnancy, pregnant or lactating women, or those with allergic constitutions; 6.Individuals with psychiatric disorders (e.g., depression, anxiety) or cognitive impairment; 7.Individuals with alcohol abuse, smoking (=10 cigarettes daily), or severely irregular schedules (e.g., staying up past 11 PM daily for =5 days per week); 8.Individuals who have taken medications or health supplements affecting trial outcomes within the past month; 9.Individuals who have participated in other clinical trials within the past three months; 10.Individuals deemed unsuitable for the clinical trial by the investigator or unable to complete the study for other reasons.

Design outcomes

Primary

MeasureTime frame
Body Composition Analysis;

Secondary

MeasureTime frame
Phlegm-Damp Constitution Traditional Chinese Medicine Syndrome Score;Blood lipid levels;Fasting blood glucose, fasting insulin, insulin resistance index;Fecal Consistency Score;Quantitative Grading Scoring Scale for Primary Symptoms of Spleen Deficiency Syndrome; Quantitative Grading Scoring Scale for Secondary Symptoms, Concomitant Symptoms and Physical Signs of Spleen Deficiency Syndrome; Quantitative Grading Scoring Scale for Tongue Manifestations of Subtypes of Spleen Deficiency Syndrome;

Countries

China

Contacts

Public ContactYangyang

The Second Affiliated Hospital of Anhui Medical University

iamyy1208333@163.com139 6503 2103

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026